Biomimetic hybrid membrane-based nanoplatforms: synthesis, properties and biomedical applications
Author:
Affiliation:
1. Marshall Laboratory of Biomedical Engineering
2. International Cancer Center
3. Laboratory of Evolutionary Theranostics (LET)
4. School of Biomedical Engineering
5. Shenzhen University Health Science Center
Abstract
This review focuses on the classification, synthesis, biomedical applications, prospects and challenges of biomimetic hybrid membrane-based nanoparticles.
Funder
National Natural Science Foundation of China
National Basic Research Program of China
Natural Science Foundation of Guangdong Province
Fok Ying Tong Education Foundation
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2020/NH/D0NH00267D
Reference74 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Molecular imaging of bacterial infections: Overcoming the barriers to clinical translation
3. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery
4. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells
5. Cancer nanomedicine: progress, challenges and opportunities
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Light responsive plasmonic nanomaterials applied to cancer phototherapy;Nanophototherapy;2025
2. Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment;Nano Today;2024-10
3. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09
4. Biomimetic Nanoparticles for the Diagnosis and Therapy of Atherosclerosis;The Chemical Record;2024-08-15
5. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy;Acta Pharmacologica Sinica;2024-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3